The UK blue chip index remains in negative territory, with little inspiration from Wall Street
- FTSE 100 down 12 points
- US stocks start mixed
- Pharma companies move higher
3.20m: Leading shares continue to drift
With little impetus from Wall Street, the FTSE 100 continues to drift rather aimlessly.
The leading index is currently down 12.62 points or 0.18% at 7082.47.
There are some bright spots. The prospect of travel over the summer as Europe and the US both began to ease restrictions continues to lift British Airways owner PLC ().
It retains its place as the top riser in the blue chip index, up 3.53%.
Medical products group (LON:SN.) has added 2.89%, supported by a postive recommendation from analysts at .
Pharmaceuticals firms are also moving higher, with PLC () adding 2.02% and () up 1.91%.
But metal price weakness has pushed miners lower, with () down 2.73% and its spin-off Ltd () 8.83% lower at 131.32p.
2.52pm: Proactive North America headlines:
() (OTC:TECXF) () says portfolio cryptocurrency company Catalyx launches Canadian dollar-backed stablecoin on top-15 global exchange
First Mining Gold Corp () () () says JV Partner at Pickle Crow Gold completes stage one earn-in
() (OTCPINK:RFHRF) (FRA:9RR) poised to start drilling at its Surimeau District battery metals project; reports more Parbec drill results
Braxia Scientific Corp () () () team-led guidelines into clinical uses of ketamine and esketamine published in prestigious American Journal of Psychiatry
Ascendant Resources Inc () (OTCMKTS:ASDRF) (FRA:2D9) begins a new preliminary economic assessment on its Lagoa Salgada project in Portugal
American Manganese Inc () () (FRA:2AM) applauds new White House report on building resilient battery supply chains in the US
Inc () () (FRA:7GU) sees ‘some very remarkable intercepts’ in Falea project exploration drilling
Ltd () (OTCQX:OGGFF) () talks possible expansion, Instacart success and the Future of Cheese in corporate…